LobbyingMilliporesigma lobbying by quarter
Milliporesigma's latest lobbying report covers Q2 2026, at $50K. The four quarters Q4 2025–Q3 2026 total $150K. Its first report covers Q3 2025; the issues it reports most are Pharmacy.
Milliporesigma
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $150K
- Last 4 quarters
- vs last quarter
- −100.0%
- Q3 2026 against the quarter before
- First report
- Q3 2025
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2025 | $30K | 1 |
| Q4 2025 | $50K | 1 |
| Q1 2026 | $50K | 1 |
| Q2 2026 | $50K | 1 |
| Q3 2026 | $0 | 0 |
By issue
- Pharmacy$180K · 4 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- Health & Human Services, Dept of (HHS)4 reports
- HOUSE OF REPRESENTATIVES4 reports
- SENATE4 reports
Firms it paid
| Firm | ||
|---|---|---|
| Todd Strategy Group | $180K | 4 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| PAUL EDATTEL | Chief Health Counsel, House Energy & Commerce Committee; Policy Assistant, Office of the Speaker; Professional Staff Member for the Majority at the House Energy & Commerce Committee; Legislative Assistant & Legislative Director, Rep. John Shadegg | Q2 2026 |
| TAYLOR SEXTON | Advisor to the Assistant Secretary for Preparedness & Response, HHS; Advisor to the Assistant Secretary of Legislation, HHS; Health Care Policy Fellow, Representative Michael Burgess | Q4 2025 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | Todd Strategy Group | $50K |
| 04/20for Q1 | Todd Strategy Group | $50K |
| 01/20for Q4 2025 | Todd Strategy Group | $50K |
| 25/10/20for Q3 2025 | Todd Strategy Group | $30K |
| 25/10/12for Q3 2025 | Todd Strategy Group | Under $5,000 |